Background There is no doubt that high doses of nicotine have deleterious effects on cardiovascular function. However, the effects of lower and more clinically relevant doses of nicotine have received little attention, and the consequences of nicotine in the setting of ischemia/reperfusion are virtually unknown. The first objective of this study was to determine whether nicotine, given either before or after ischemia and at a dose mimicking that absorbed by humans during inhalation of one cigarette, exacerbated contractile dysfunction of canine myocardium "stunned" by brief transient ischemia. The second aim was to provide preliminary insight into the mechanism of action of nicotine on the stunned myocardium. Methods and Results Anesthetized open chest dogs underwent 15 minutes of left anterior descending coronary artery (LAD) occlusion and 3 hours of reperfusion. In protocol 1, each dog was randomized to receive nicotine at 30 minutes before LAD occlusion (80 gg/kg dissolved in 15 mL of saline, given IV over 10 minutes), nicotine at 1 hour after reperfusion (80 ,ug/kg as above), or saline. Segment shortening (assessed by sonomicrometry) in both the LAD and circumflex beds, heart rate, arterial pressure, and coronary blood flow were monitored throughout the protocol, and regional myocardial blood flow (by injection of radiolabeled microspheres) was measured during LAD occlusion and at 5 minutes after nicotine/saline infusion. All groups were equally ischemic during LAD occlusion. As expected, segment shortening in the LAD bed of control animals was depressed after reperfusion, averaging 54±6% and 50±4% of baseline at 1 and 3 hours after reflow. Nicotine given before occlusion did not alter segment shortening before LAD occlusion and did not exacerbate dyskinesis during occlusion. However, segment short-
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Conclusions Nicotine, given before occlusion or after reflow, significantly exacerbated contractile dysfunction of postischemic stunned myocardium in this canine model. This exacerbated dysfunction was not a secondary consequence On the basis of these data, one might predict that high doses of nicotine, if present in the setting of myocardial ischemia/reperfusion, would further worsen the imbalance between myocardial oxygen supply and demand and thereby exacerbate injury to the heart. In fact, two previous studies have reported that nicotine increased the extent of myocardial necrosis in the canine model of permanent coronary artery occlusion.9'10 But of perhaps greater interest is the preliminary and unexplained evidence of increased infarct size, in this case after exposure to cigarette smoke, when coronary ligation was performed at 1 day after blood nicotine levels had been restored to baseline values." Surprisingly, however, the effects of lower and more clinically relevant doses of nicotine on the ischemic myocardium have received little attention, and the consequences of nicotine in the setting of ischemia/ reperfusion are virtually unknown. Thus, the primary aim of this study was to determine whether nicotine, given either before or after ischemia, and at a dose mimicking the amount absorbed by smokers during inhalation of one cigarette,3 further worsened myocardial injury and dysfunction of canine myocardium "stunned" by a brief episode of transient ischemia. The second objective was to provide preliminary insight into the mechanism of action of nicotine on the ischemic/ reperfused myocardium. The results reveal that a slow, low-dose infusion of nicotine exacerbated postischemic dysfunction -in the apparent absence of unfavorable alterations in hemodynamics or myocardial perfusion -in this canine model of angina and provide evidence that suggests that this deleterious effect of nicotine on the stunned myocardium may be mediated by free radicals.
Methods
This study was approved by the Institutional Animal Care and Use Committee of the Hospital of the Good Samaritan (an AAALAC-accredited institution) and conforms with the "Position of the American Heart Association on Research Animal Use" (Circulation. 1985;71:849).
Surgical Preparation
Forty-seven mongrel dogs weighing 21±3 kg (mean±SD) were anesthetized, intubated, and ventilated with room air. After cannulating the left carotid artery (for measurement of heart rate and arterial pressure) and the left jugular vein (for administration of drugs and fluids), the heart was exposed through a left lateral thoracotomy and suspended in a pericardial cradle. A microtipped pressure transducer was positioned in the left ventricular (LV) cavity via the left atrial appendage for measurement of LV pressure and its first derivative dP/dt, and a cannula was inserted in the left atrial appendage for later injection of radiolabeled microspheres (141Ce, 103Ru, or 95Nb) for measurement of regional myocardial blood flow (RMBF). Two segments of the left anterior descending coronary artery (LAD) were isolated, usually just distal to the first major diagonal branch: one for later placement of occlusive vascular clamps, and the second for placement of a Doppler ultrasonic flow probe for measurement of mean coronary blood flow (CBF).
Regional contractile function in both the soon-to-be ischemic and normally perfused myocardium was assessed by sonomicrometry, the details of which have been described previously.12-15 Briefly, one pair of ultrasonic crystals, used to monitor segment shortening, was inserted through small scalpel incisions into the midmyocardium in the center of the LAD bed and oriented parallel to the minor axis of the heart. A second pair of crystals was similarly positioned well within the territory of the normally perfused circumflex coronary artery. After the preparation had stabilized, baseline measurements of segment lengths, CBF, arterial and LV pressures, and dP/dt were obtained. All dogs underwent 15 minutes of LAD occlusion followed by 3 hours of reperfusion, with regional contractile function and hemodynamic parameters monitored continuously throughout each experiment on a Gould recorder.
Protocol 1: Effect of Nicotine on Stunned Myocardium
After baseline measurements had been obtained, the first 34 dogs in the study were randomly assigned to receive nicotine before coronary occlusion, nicotine after coronary occlusion, or saline. Specifically, each dog received two 10-minute infusions into the jugular vein, the first begun at 30 minutes before coronary occlusion and the second begun at 1 hour after reperfusion. The "nicotine preocclusion" group received nicotine (Sigma Chemical Co, 80 ,ug/kg dissolved in 15 mL of saline) during the first infusion and saline (15 mL) during the second, the "nicotine postreperfusion" group received saline during the first infusion and nicotine during the second, and the control group received two infusions of saline. The dose of nicotine was chosen on the basis of previous research by Folts and Bonebrake,3 and the infusions were administered slowly in an effort to minimize the well-described acute hemodynamic effects of nicotine.
The primary end point of the study was regional contractile function. Segment shortening in both the LAD and circumflex beds was measured at 5-minute intervals during infusions of nicotine or saline, immediately before coronary occlusion, at 5 minutes after the onset of LAD occlusion, and throughout the first 3 hours of reperfusion. Hemodynamics and CBF were also recorded at each of these time points. In addition, RMBF was assessed by injection of radiolabeled microspheres at 5 minutes after the first infusion, during coronary occlusion, and at 5 minutes after the second infusion.
At 3 hours after reperfusion, the LAD was ligated at the site of previous occlusion, and Unisperse blue pigment (0.25 to 0.5 mL/kg) was injected into the coronary vasculature through the left atrial catheter to delineate the in vivo extent of the occluded coronary artery bed or area at risk. While under deep anesthesia, the dogs were killed by intracardiac injection of KCl. The hearts were rapidly excised and cut into five to seven transverse slices parallel to the atrioventricular groove, and the basal surface of each heart slice was photographed for later measurement of area at risk. Correct placement of the ultrasonic crystals within the center of the LAD and circumflex territories was confirmed in each heart. The heart slices were then incubated for 10 The final 13 animals were entered into the second limb of the study, in which all dogs received the free radical scavenging agent N-2-mercaptopropionyl glycine (MPG; Sigma, 50 mg * kg`. h-1 dissolved in 50 mL of saline).17 Infusion of MPG was begun at 45 minutes after reperfusion through the left atrial catheter and continued for the remainder of the protocol. After MPG infusion had started, each dog was randomized to receive one 10-minute infusion of either nicotine or saline, initiated at 1 hour after reperfusion, as described in protocol 1. No infusion of nicotine/saline was given before occlusion in these animals.
Segment shortening and hemodynamics were monitored throughout each experiment as described in protocol 1. (CBF was not, however, measured.) RMBF was assessed during coronary occlusion and at 5 minutes after nicotine or saline infusion. The in vivo extent of the area at risk was delineated as described previously, and correct placement of the ultrasonic crystals was confirmed.
Analysis Hemodynamics
Heart rate, mean arterial pressure, and CBF were measured and averaged over five continuous cardiac cycles in sinus rhythm for each sample period.
Segment Shortening
LV dP/dt was used to define the segment length (or separation between the pairs of ultrasonic crystals) during the cardiac cycle: end-diastolic lengths (EDLs) were measured at 
Area at Risk and Area of Necrosis
After fixation, right ventricular tissue was trimmed from each heart slice, and the slices were weighed. Photographic slides of the heart slices were projected at magnifications of x 2 to x4 and traced. The extent of the area at risk (ie, regions of myocardium devoid of blue dye) and area of necrosis (ie, any tissue not stained by TTC) in each slice were measured by computerized planimetry, corrected for the weight of the tissue slice, and summed for each heart. 
Regional Myocardial Blood Flow
Blocks of tissue weighing 2 to 3 g were cut both from the center of the LAD and circumflex territories and subdivided into subendocardial, midmyocardial, and subepicardial segments. RMBF was then quantified using the standard technique of Domenech et al.18 Exclusions No attempt was made to resuscitate dogs that developed ventricular fibrillation either during coronary occlusion or at the time of reperfusion. The only exclusion criterion for animals surviving the protocol was the incorrect placement of the ultrasonic crystals-ie, at the margin of the area at risk, rather than in the center of the LAD or circumflex beds.
Statistical Analysis
Because the design of the study was such that protocols 1 and 2 were done sequentially (not concurrently), statistical analysis was performed separately for each of the two protocols.
For protocol 1, comparisons of discrete variables among the three treatment groups were made using one-way ANOVA, whereas comparisons of variables measured repeatedly during the protocol were made using two-factor ANOVA (for treatment and time) with repeated measures across the second factor. If significant F ratios were obtained, pairwise comparisons were made using Tukey's test. 19 Segment shortening in the LAD and circumflex beds was compared among the groups during coronary occlusion and at 1 and 3 hours after reperfusion, whereas hemodynamics were compared at baseline, at 10 minutes after the onset of nicotine/saline infusion, during coronary occlusion, and at 1 and 3 hours after reflow. For protocol 2, comparisons of discrete variables between the two groups were made using t tests, and comparisons of segment shortening and hemodynamics at the time points listed above were made using two-factor ANOVA.
All data are expressed as mean+± SEM, and values are considered to differ significantly if P<.05.
Results
Protocol 1: Effect of Nicotine on
Stunned Myocardium
Of the 34 dogs entered into the first limb of the study, 1 developed ventricular fibrillation during placement of the atrial catheters (ie, before randomization), 3 fibrillated during coronary occlusion (1 control and 2 randomized to receive nicotine postreperfusion), and 3 died at the time of reperfusion (1 in each of the treatment groups). In addition, 1 dog that received nicotine postreperfusion was excluded because of incorrect placement of the ultrasonic crystals. The remaining 26 dogs are included in the final analysis: 9 in the control group, 9 treated with nicotine before coronary occlusion, and 8 treated with nicotine after reperfusion.
Area at Risk and Area of Necrosis
The in vivo extent of the occluded LAD bed averaged 22+2%, 23+2%, and 20±2% of the LV in dogs that received saline, nicotine before occlusion, and nicotine after reperfusion, respectively (P=NS).
As expected,12-1517,20 15 minutes of coronary artery occlusion in control animals did not result in myocardial necrosis. Similarly, the nicotine-treated groups showed no evidence of infarction as detected by TTC staining. Hemodynamics Heart rate, mean arterial pressure, and CBF were not altered significantly by infusion of either nicotine or saline (Table 1) . For example, in the control group, mean arterial pressure in response to the first infusion of saline averaged 126±7, 128+7, and 131±7 mm Hg at baseline, 5 minutes, and 10 minutes after infusion, respectively (P=NS). Similarly, in the nicotine before occlusion group, mean arterial pressure was 122±6, 127±6, and 128±5 mm Hg at baseline, 5 minutes, and 10 minutes after nicotine infusion (P=NS). Moreover, there were no differences in heart rate, mean arterial pressure, or CBF among the three treatment groups at any time during the protocol. Regional Myocardial Blood Flow RMBF measured at 5 minutes after nicotine/saline infusion did not differ between the control and nicotinetreated groups in either the LAD or circumflex territories (Table 2 ). For example, subendocardial RMBF in the soon-to-be ischemic LAD bed after the first infusion was 0.96±0.11, 1.00±0.13, and 0.94±0.09 mL* min-l* g`in the control, nicotine before occlusion, and nicotine after reperfusion groups, respectively (P=NS). In addition, blood flow during LAD occlusion did not differ between In control animals, the first infusion of saline had no effect on segment shortening during the 30 minutes before coronary artery occlusion (Fig 1 and Table 4 ). All dogs in the control group exhibited dyskinesis in the LAD bed during LAD occlusion, and, as expected, segment shortening remained depressed or "stunned" after reperfusion, recovering to a mean of 54+6% of baseline at 1 hour after reflow. Infusion of saline at 1 hour after coronary occlusion had no effect on regional contractile function of the stunned myocardium; segment shortening at 3 hours after reflow was maintained at 50+4% (P=NS versus 1 hour after reperfusion; Fig 1) .
In the nicotine preocclusion group, infusion of nicotine did not alter regional wall motion in the LAD bed during the 30 minutes before LAD occlusion; segment shortening remained constant at 95% to 98% of baseline values. In addition, pretreatment with nicotine had no effect on the severity of dyskinesis during subsequent LAD occlusion compared with controls. However, segment shortening was restored to only 29+9% and 22+5% of baseline at 1 and 3 hours after relief of ischemia, significantly lower than the values of 54% (P<.01) and 50% (P<.01) observed in the control group (Fig 1) .
In animals randomized to receive nicotine after reperfusion, segment shortening at 1 hour after reflow (ie, immediately before treatment) was 47+11%, similar to the control value of 54±6% (P=NS). However, on infusion of nicotine, segment shortening deteriorated in every dog in this group and, at 3 hours after reperfusion, averaged only 7±13% of baseline (P<.01 versus 1 hour after reperfusion; P<.01 versus control value of 50±4% at 3 hours after reperfusion; Fig 1) .
Similar results were obtained when absolute values of segment shortening were compared among the three groups (Table 4) .
Protocol 2: Role of Free Radicals in the Response to Nicotine
Of the 13 dogs entered into protocol 2, 5 were excluded because of ventricular fibrillation: 2 fibrillated during occlusion, and 3 died on reperfusion. All deaths occurred before randomization and treatment. Of the 8 survivors, 6 received MPG plus nicotine, and 2 received MPG plus saline.
Area at Risk
Area at risk was similar in both groups, averaging 22±6% of the LV in animals that received MPG plus saline and 20±2% of the LV in animals that received MPG plus nicotine (P=NS).
Hemodynamics
Heart rate and mean arterial pressure did not differ between the two treatment groups and were similar to values obtained in protocol 1 (Table 5 ).
Regional Myocardial Blood Flow
Both groups were equally ischemic during LAD occlusion; subendocardial RMBF in the LAD bed was 0.06±0.03 and 0.04±0.02 mL * min-1 g-1 in dogs that later received MPG plus saline and MPG plus nicotine, respectively (P=NS) ( Table 6 ). RMBF in both the LAD and circumflex territories at 5 minutes after nicotine/saline infusion was similar in both groups. In addition, RMBF after nicotine/saline infusion in protocol 2 was similar to that observed after the second nicotine/saline infusion in protocol 1, suggesting that neither nicotine nor MPG altered myocardial perfusion.
Segment Shortening: Normally Perfused Circumflex Bed
Segment shortening in the circumflex bed did not differ between the two treatment groups at any time during the protocol (Table 7) . Segment Shortening: Ischemic/Reperfused LAD Bed All animals in protocol 2 were dyskinetic during LAD occlusion, and all dogs exhibited hypokinesis after relief of ischemia (Fig 2 and Table 8 ).
As expected,20 MPG administered 45 minutes after reperfusion had no significant beneficial effect on contractile function of the stunned myocardium; segment shortening averaged 50% to 59% of baseline values at both 45 minutes after reperfusion (ie, immediately before MPG infusion) and at 1 hour after reflow (immediately before nicotine/saline infusion) in both treatment groups (Fig 2) .
In dogs that then received saline, segment shortening, as expected, remained unchanged at 59% of baseline values at both 1 and 3 hours after reperfusion. Similarly, in dogs then treated with nicotine, segment shortening remained constant, averaging 54±11% and 56±9% at 1 and 3 hours after reperfusion (Fig 2) . Absolute values of segment shortening were also comparable between the two groups throughout the protocol (Table 8) . That is, infusion of the scavenging agent MPG prevented the deterioration in postischemic function observed with infusion of nicotine in protocol 1.
Discussion
The results of the present study reveal that a slow, low-dose infusion of nicotine, given either before occlusion or after reperfusion, significantly exacerbates contractile dysfunction of myocardium "stunned" by brief transient ischemia. This effect appears to be selective for the ischemic/reperfused tissue in that function in the normally perfused myocardium was not altered by nicotine infusion. In addition, the effect is not a secondary consequence of unfavorable changes in hemodynamics or myocardial perfusion and is not explained by nicotine-induced necrosis. Rather, evidence from protocol 2 suggests that the exacerbated dysfunction associated with infusion of nicotine may be mediated by free radicals acting on myocytes that had been reversibly injured by the brief ischemic insult.
Acute Physiological Effects of Nicotine
The immediate physiological responses to nicotine have been extensively characterized in healthy humans shortening in normally perfused myocardium increased to 175% of baseline values, and myocardial oxygen consumption increased from 8.9 to 17.9 mL 02 per min/100 g during continuous IV infusion of nicotine at a rate of 36 ,g. kg-'min-'. In contrast, the acute effects of nicotine on CBF in the normally perfused heart are less conclusive. Intravenous infusion of nicotine at a rate of 36 ,ugg kg`min-' has been shown to acutely increase coronary flow (ie, from 32 to 82 mL/ min) due to sympathetic activation.4 However, others have reported vasoconstriction and reduced blood flow with administration of nicotine (perhaps because of local parasympathetic stimulation and inhibition of prostacyclin synthesis) despite concomitant increases in myocardial oxygen demand.1"2'6 Given these previous reports, why were no changes in hemodynamics or CBF observed with nicotine infusion in the present study? The design of protocol 1 was such that the statistical power was sufficient to register a difference in mean arterial pressure on the order of 20 to 25 mm Hg as being significant, a difference well within the range of those reported previously with nicotine infusion. The most probable explanation is the dose of nicotine that was given -80 ,gg/kg over 10 minutes (ie, 8 gg. kg`. min-') in the present study versus 36 ,g kg.*min-1 in the protocol of Downey et al. 4 The rate of infusion would also appear to play a role; although 80 a£g/kg infused over 10 minutes did not alter hemodynamics or CBF, Folts and Bonebrake3 found that 80 jig/kg given over 4 to 5 minutes increased mean arterial pressure (albeit less dramatically) from 118 to 156 mm Hg. This is further supported by observations made in preliminary experiments, in which we found that simply flushing the remaining contents of the venous catheter at the end of the nicotine infusion precipitated marked but short-lived hemodynamic effects; ie, in one instance, mean arterial pressure increased rapidly (within seconds) from 160 mm Hg at the end of infusion to 215 mm Hg but normalized within 5 minutes. The low dose and slow rate of administration of nicotine used in this protocol was, in fact, chosen in an effort to minimize these profound hemodynamic effects.
Nicotine in Myocardial Ischemia and Infarction
These previous studies suggest that nicotine, if administered in the setting of acute myocardial ischemia, may further worsen the imbalance between myocardial oxygen supply and demand and thereby exacerbate myocardial injury and dysfunction beyond that caused by ischemia per se. In fact, Sridharan et a19 observed that dogs given daily intravenous infusions of nicotine (1.2 mg/d, or, more specifically, 800 ,ug/min, 15 minutes per day, for Importantly, however, interpretation of the data is confounded by the fact that these studies were performed before measurements of collateral blood flow, risk region, and quantitation of infarct size by macroscopic staining were considered de rigueur. That is, we cannot exclude the possibility that the differences in the volume of infarcted myocardium were simply the result of chance differences in the major determinants of infarct size (particularly collateral blood flow) between the control and nicotine-treated groups.
More recently, a preliminary report by Prentice et al"l has shown that infarcts produced by 6 hours of permanent coronary artery occlusion in dogs exposed to cigarette smoke (1 h/d for 10 days) were twice as large as those observed in control animals. Interestingly, infarct size was greater in the smoke-treated group despite the fact that coronary occlusion was initiated at 24 hours after the final smoke exposure, a time at which blood nicotine levels were no longer elevated.1" Collateral blood flow and hemodynamics were not, however, presented, and no explanation was offered for this exacerbated necrosis at 1 day after smoke exposure.
Effect of Nicotine on the Stunned Myocardium: Potential Mechanism(s)
The present study assessed the effects of slow, lowdose nicotine infusion on the well-documented canine model of the stunned myocardium. Results obtained in the saline control groups are in accord with previous reports from our laboratory and many others 1-57520; segment shortening of the viable, previously ischemic myocardium remained depressed throughout the initial 3 hours after reperfusion. It could be argued that the recovery of contractile function in the present study was somewhat better than the values of 0% to 30% that have been reported previously.12-15 Aside from the welldescribed variability in the canine model, this difference in all likelihood reflects the fact that in previous studies seeking to enhance function of stunned myocardium by various pharmacologic interventions, analysis was limited to the subgroup of dogs that were severely ischemic during LAD occlusion and thus severely stunned after reperfusion.13-"5 In contrast, in the present study, no exclusions were made on the basis of myocardial perfusion; each group contained dogs that would, by our usual criteria, be considered to have high collateral flow.
Protocol 1 revealed that nicotine, given either before occlusion or after reperfusion, significantly exacerbated contractile dysfunction of the stunned myocardium after relief of ischemia when compared with saline controls. The obvious question is, How can this exacerbated dysfunction be explained? Hemodynamics, CBF, and Nicotine-Induced Necrosis Three potential mechanisms can be effectively excluded. First, differences in recovery of segment shortening between control and nicotine-treated groups were not the result of differences in the severity of ischemia during LAD occlusion and could not be attributed to differences in the extent of the myocardium at risk. Second, the benign hemodynamic profile of nicotine in this study argues against the possibility that the poor recovery of function in the nicotine-treated groups was the result of unfavorable changes in heart rate or arterial pressure. A third possibility is that nicotine may have caused myocyte necrosis, but we saw no evidence of infarction, as detected by TTC, in any of the dogs in the study. This issue was further pursued by examining histological sections stained with hematoxylin and eosin taken from the center of the ischemic/repertused LAD bed of six dogs in protocol 1; three controls and the three dogs given nicotine postreperfusion that showed the greatest deterioration in segment shortening between 1 and 3 hours after reflow. Blinded inspection of the sections by routine light microscopy showed no qualitative differences among animals, and quantitative assessment by polarized light microscopy revealed no difference in myocyte birefringence (an early marker of tissue injury)21 between control and nicotine-treated dogs.
Previous studies have shown that in addition to its hemodynamic consequences, nicotine has potentially deleterious hematologic effects, including increased hematocrit,2,3 increased platelet activity and aggregation,1-3 and increased sequestration and activation of neutrophils.7'8 Each of these three factors could conceivably exacerbate contractile dysfunction of the stunned myocardium by compromising myocardial blood flow after reperfusion, ie, by increasing blood viscosity and/or obstructing the coronary microcirculation.2223 This did not, however, appear to be the case in the present study; neither CBF nor RMBF was acutely altered by nicotine infusion, and CBF was similar among control and nicotine-treated groups throughout the protocol. Moreover, there was no indication of enhanced neutrophil influx or platelet aggregation with administration of nicotine in the subset of dogs in which histological sections were obtained. This does not, however, exclude the possibility that neutrophils in the ischemic/reperfused LAD bed may have been activated by infusion of nicotine. Role of Free Radicals?
Considerable evidence indicates that postischemic dysfunction of viable but stunned myocardium after brief ischemia is due, at least in part, of toxic oxygenderived free radicals generated at the time of reperfusion. 1 It was this established link between oxygen radicals and contractile dysfunction that provided the rationale for the second limb of the present study; once the potential hemodynamic explanations had been dismissed, we sought to determine whether the exacerbated dysfunction of stunned myocardium in the nicotine-treated groups might also be the result of a free radical-mediated mechanism. To address this issue, both control and nicotine-treated animals in protocol 2 received the free radical scavenging agent MPG beginning at 45 minutes after relief of ischemia. Importantly, the MPG (and therefore the nicotine/saline) was given well after blood flow had been restored and not during occlusion/reperfusion. This was done in an effort to blunt the effects of the nicotine infusion per se, without attenuating free radical-mediated dysfunction resulting from ischemia/reperfusion. As expected from the work of Bolli and colleagues,20 we confirmed that MPG plus saline given after reperfusion had no beneficial effect on the stunned myocardium. However, continuous infusion of MPG prevented the deterioration in segment shortening observed with nicotine in the first protocol.
Although these data provide indirect evidence that nicotine, when given after reperfusion, exacerbated contractile dysfunction of the stunned myocardium by a free radical-mediated mechanism, several issues remain unresolved. First, the mechanism of action of nicotine given before coronary occlusion was not addressed in this study. However, as nicotine has a plasma half-life of 2 hours,1 it is possible that both regimens may exacerbate postischemic dysfunction by a common pathway. Second, the identity, source, and site of action of the culprit free radical species are unknown. The concept that nicotine may amplify oxidative injury in the setting of myocardial ischemia/reperfusion is not, however, without precedent; van Jaarsveld et a127 found that exposure of rats to low concentrations of cigarette smoke impaired mitochondrial oxidative function after 10 minutes of global ischemia, perhaps due to an increase in hydroxyl radical production and depletion of the endogenous antioxidant a-tocopherol. Finally, it is interesting to note that nicotine infusion did not alter contractile function of the normally perfused circumflex territory. This suggests that nicotine may have entered the reversibly injured myocytes (perhaps via "leaky" membranes) and oxidized cellular proteins and/or membrane lipids but was unable to enter cells and cause dysfunction within regions of the heart in which the myocyte membranes were presumably intact. Summary, Implications, and Limitations
The concept that nicotine in particular, and exposure to cigarette smoke in general, is deleterious to the heart is certainly not new. Numerous epidemiologic studies have assessed the importance of smoking as a risk factor in coronary artery disease,2 the adverse effects of "second-hand" smoke have received considerable attention,28 and many of the large clinical trials have performed subgroup analysis to compare outcome after myocardial infarction in smokers versus nonsmokers. 29 However, the present study is, to our knowledge, the first experimental protocol to specifically assess the consequences of a physiologically relevant dose of nicotine on myocardial contractile dysfunction in the setting of transient ischemia/reperfusion. Although extrapolation of these data must be made with caution, the results suggest that postischemic dysfunction in patients with angina may be exacerbated in smokers versus nonsmokers or in patients exposed to nicotine via passive smoking. The exacerbated dysfunction of stunned myocardium seen with low-dose nicotine in this canine model suggests that the effects of smoking, passive smoking, or nicotine per se on recovery of wall motion after transient ischemia is a topic that warrants further investigation.
